Why stocks are in for a rough ride this week
Stocks in for a rough ride this week

Longtime market bull Jeremy Siegel says investors could realize the market is behind the curve on interest rates.


Capital Advisors Growth Fund manager Keith Goddard works to limit losses while maintaining potential for aggressive growth.

By TheStreet Staff Nov 23, 2011 3:10PM

the streetBy Stan Luxenberg


All too often, large growth funds have followed a volatile pattern. During bull markets, the growth funds soared as investors bid up prices of fast-moving technology and consumer stocks. Then the rally ended and growth stocks crashed hard as overvalued shares sank.


Because of the regular collapses, the large growth category has often trailed large value. From 1928 through 2010, large growth stocks returned 8.8% annually, compared to a figure of 11.1% for large value, according to Ibbotson Associates. In recent years, growth stocks have sunk twice -- after the Internet bubble burst in 2000 and when the financial crisis unfolded in 2008. Hurt by the downturns, large growth funds trailed the S&P 500 ($INX) during the past decade, while large value funds outdid the benchmark.


The stock has now dropped below its $20-per-share IPO price.

By TheStreet Staff Nov 23, 2011 2:54PM

Updated: 4:35 p.m. ET


By Olivia OranTheStreet

Shares of Groupon (GRPN), which soared 40% two weeks ago during the daily deal site's IPO, continued to crater on Wednesday.


The stock fell 15.5% to $16.96. The session low was $16.84. Volume continued to be elevated with more than 5 million shares changing hands by midday. Wednesday's decline follows a 15% drop on Tuesday.


The health care products maker is spending $325 million on a private company to bolster its presence in the gastrointestinal diseases therapy space.

By Zacks.com Nov 23, 2011 2:27PM

By: Zacks Equity Research


Leading health care products maker Covidien (COV) has cut a deal to buy the outstanding shares of Barrx Medical for $325 million, hoping the move will boost its presence in the gastrointestinal diseases therapy space.


Barrx Medical makes ablation catheters and other devices for treating gastrointestinal diseases and Barrett’s esophagus syndrome, a pre-cancerous condition of the lining of the esophagus.

Tags: JNJ

The farm machinery maker saw quarterly sales rise 20% from a year earlier to $8.6 billion.

By Zacks.com Nov 23, 2011 2:16PM

Image: Combines in field (© Mark Karrass/Corbis/Corbis)Deere & Co. (DE) outperformed in its fourth quarter, riding a wave of strong demand for farm machinery and increased sales of construction equipment.

The equipment maker delivered earnings of $1.62 per share in the quarter ended Oct. 31, comfortably exceeding the Zacks Consensus Estimate of $1.44. Results were 51% ahead of the $1.07 earned in the year-ago quarter.


Early indicators show that Black Friday could be a hit for retailers. Will the rest of the holiday season follow suit?

By Jonathan Berr Nov 23, 2011 1:57PM
Image: Woman with shopping bags (© Tanya Constantine/Getty Images)Shoppers are already camped out at stores across the country in hopes of landing the best Black Friday deals.  

Retailers are hoping that their enthusiasm signals a strong performance for Black Friday, the traditional start of the holiday season. The National Retail Federation recently said that more Americans say they plan to shop for Black Friday bargains than last year. Consumer confidence rose in November to its highest level in November to its highest level in five months. 

The two drug companies end a rocky 10-year partnership. What's next for Amylin?

By TheStockAdvisors Nov 23, 2011 1:21PM
By John McCamant, The Medical Technology Stock Letter

Amylin (AMLN) made news recently when it was announced that Eli Lilly (LLY) had broken a deal between the companies for two Type 2 diabetes treatments, Byetta and Bydureon. 

Amylin has also settled a marketing lawsuit it filed against Lilly this year alleging anti-competitive activity after Lilly entered into a marketing deal with Boehringer Ingelheim to sell a competing diabetes drug.

The divorce ends a rocky 10-year partnership between the two companies. 

We expect the automaker to rein in development costs after completing work on the Model S and a new plant.

By Trefis Nov 23, 2011 12:37PM
Tesla Motors' (TSLA) revenue jumped substantially in the third quarter due to strong demand for its Roadster model, higher powertrain component sales and increased payments for development work on Toyota's (TM) RAV4 EV.

But Tesla's costs also increased substantially year over year, primarily due to higher research and development expenses. 
Tags: TSLA

While the market's pullback to key support is a caution sign for now, it’s also likely to result in a rally next week -- one critical to the market’s intermediate-term future.

By MoneyShow.com Nov 23, 2011 12:27PM

By Tom Aspray, MoneyShow.com

The heavy selling Monday and additional losses on Tuesday have taken the major averages to the next key areas of support. Additional selling in the S&P futures early Wednesday has taken them below the 50% Fibonacci support levels.

For those not familiar with Fibonacci analysis, if prices break below the 50% support, it implies that prices will then drop to the 61.8% support. A daily close below that level will give confirmation that the trend has changed from up to down. Of course, in declining markets, we watch to see if the 38.2% retracement resistance is overcome, and if it is, we then look at the 50% and 61.8% retracement resistance levels.


The aircraft maker's recent 200-plane order from American Airlines' parent now looks a lot shakier.

By InvestorPlace Nov 23, 2011 12:24PM
Image: Airline (© Christie & Cole/Corbis)By Susan J. Aluise, Aviation, Auto & Transportation Writer

Although the congressional supercommittee's colossal failure this week points to the near certainty of massive defense cuts, few analysts are shedding tears for Boeing (BA) right now. One reason is the nearly $40 billion in orders the aircraft maker has booked this month alone.

But trouble looms for Boeing in the fine points of this summer's 200-plane deal with struggling American Airlines parentAMR Corp. (AMR).


JPMorgan has brought in the most investment banking revenue for at least seven consecutive quarters, but it may lose its crown as 2011 comes to a close.

By TheStreet Staff Nov 23, 2011 12:14PM

By Dan FreedTheStreet


Bank of America (BAC) is threatening to edge out JPMorgan Chase (JPM) as the top investment bank in terms of revenues in the fourth quarter, according to a research report published Tuesday.


JPMorgan's investment banking division has brought in more revenues than its counterparts at other banks in every quarter going back to at least the first quarter of last year, according to the Barclays Capital report, which cites Dealogic data.


With no way of knowing how the eurozone crisis will play out, investors should continue to exercise extreme caution by holding cash and high-yield stocks.

By Jim Cramer Nov 23, 2011 11:17AM

the street logoSo many disparate voices. So many people talking to you. The IMF on a lifeline -- how big? A Spanish prime minister. An aide close to Merkel. Someone close to Sarkozy. Nameless people in the Greek government. Finance ministry people from Italy. ECB bureaucrats. Who the heck knows?


And that's what's so hard about this tape. Sure, we can look to the CurrencyShares Euro Trust (FXE). When it drops off, we know we are going to have a tough day, but all we can do is root around to find out why it is dropping off.


Believe it or not, technical and fundamental underpinnings signal gains ahead. These stock picks make sense now.

By Gene Marcial Nov 23, 2011 11:16AM

Don't panic. That's the No. 1 rule that investors should keep in mind during intensely volatile market swings. More specifically, investors should not be goaded into panic selling.


I am aware that that isn't easy to do. But the market will get better. In fact, several seasoned and savvy pros argue that the market's current technical and fundamental underpinnings signal that it's time to buy U.S. stocks ahead of what they expect will be a sharp snap-back in equity prices.


Demand for office products is closely tied to the health of the economy, which is showing no sign of revival.

By Zacks.com Nov 23, 2011 12:55AM

Image: Person signing paperwork, mid section © PhotoAlto/Eric Audras/PhotoAlto Agency RF/Getty ImagesStaples (SPLS) unveiled its third-quarter results on Nov. 15. The quarterly earnings of 47 cents a share came in line with the Zacks Consensus Estimate and jumped 14.6% from 41 cents earned a year earlier.


Total sales of $6.57 billion were up .5% from the prior-year quarter but below the Zacks Consensus Estimate of $6.7 billion. North American delivery sales grew 1.8%, North American retail sales inched up .5% but international sales contracted 1.9%.

Tags: SPLS

This pick is the best way to play an anticipated price increase.

By Jim J. Jubak Nov 22, 2011 6:15PM
If you’re like me, the second quarter of 2012 seems a long way off, and the idea of buying anything seems, well, just plain stupid.

But I think it's worth paying attention to this report on copper out of Goldman Sachs (GS) Monday. It's just the kind of long-term thinking -- what does it say that I’m calling six months long term? -- that we could all use a dose of in a market like this.
Tags: FCX

The home glut is having a domino effect on retailers like carpet makers and home décor specialists.

By The Fiscal Times Nov 22, 2011 5:24PM

Image: Home with foreclosure sign in front yard © Ariel Skelley/Stockbyte/Getty ImagesBy Suzanne McGee, The Fiscal Times

First, the good news: Existing home sales rose 1.4% in October to 4.97 million units -- more than the 4.8 million economists had expected. That’s going to help the supply overhang shrink a bit.

Still, Ian Shepherdson, chief U.S. economist at High Frequency Economics, argues that it will take until next spring and an increase in payroll earnings for the supply overhang to diminish and for a real recovery in the market to take place.



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

120 rated 1
268 rated 2
439 rated 3
709 rated 4
641 rated 5
609 rated 6
640 rated 7
516 rated 8
272 rated 9
152 rated 10

Top Picks

TAT&T Inc9

Trending NOW

What’s this?



Quotes delayed at least 15 min


Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] Equity indices continue drifting near their best levels of the day, but the energy sector (-0.4%) has recently tumbled to a fresh low amid a decline in the price of crude. The energy component is now lower by 1.2% at $93.32/bbl after trading little changed at the start of the session.

Outside of energy, the utilities sector (-0.7%) is the only other decliner. Elsewhere among countercyclical groups, the consumer staples sector underperforms, but has been able to stay out ... More


There’s a problem getting this information right now. Please try again later.